Outset Medical Inc (OM) - Total Assets
Based on the latest financial reports, Outset Medical Inc (OM) holds total assets worth $249.45 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Outset Medical Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Outset Medical Inc - Total Assets Trend (2018–2025)
This chart illustrates how Outset Medical Inc's total assets have evolved over time, based on quarterly financial data. See Outset Medical Inc book value and equity for net asset value and shareholders' equity analysis.
Outset Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Outset Medical Inc's total assets of $249.45 Million consist of 94.9% current assets and 5.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.2% |
| Accounts Receivable | $28.33 Million | 10.7% |
| Inventory | $47.61 Million | 18.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Outset Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Outset Medical Inc.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Outset Medical Inc's current assets represent 94.9% of total assets in 2025, a decrease from 97.7% in 2018.
- Cash Position: Cash and equivalents constituted 13.2% of total assets in 2025, down from 22.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is inventory at 18.0% of total assets.
Outset Medical Inc Competitors by Total Assets
Key competitors of Outset Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Outset Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.29 | 8.37 | 12.64 |
| Quick Ratio | 4.97 | 6.74 | 11.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $199.10 Million | $252.34 Million | $412.52 Million |
Outset Medical Inc - Advanced Valuation Insights
This section examines the relationship between Outset Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.61 |
| Latest Market Cap to Assets Ratio | 0.26 |
| Asset Growth Rate (YoY) | -4.1% |
| Total Assets | $264.50 Million |
| Market Capitalization | $67.66 Million USD |
Valuation Analysis
Below Book Valuation: The market values Outset Medical Inc's assets below their book value (0.26x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Outset Medical Inc's assets decreased by 4.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Outset Medical Inc (2018–2025)
The table below shows the annual total assets of Outset Medical Inc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $264.50 Million | -4.10% |
| 2024-12-31 | $275.80 Million | -12.11% |
| 2023-12-31 | $313.80 Million | -21.57% |
| 2022-12-31 | $400.12 Million | -13.67% |
| 2021-12-31 | $463.46 Million | +14.77% |
| 2020-12-31 | $403.83 Million | +357.00% |
| 2019-12-31 | $88.37 Million | -41.53% |
| 2018-12-31 | $151.13 Million | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more